# Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall

> **NCT00089544** · PHASE2 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 23 (actual)

## Conditions studied

- Recurrent Adult Soft Tissue Sarcoma
- Stage I Adult Soft Tissue Sarcoma AJCC v7
- Stage II Adult Soft Tissue Sarcoma AJCC v7
- Stage III Adult Soft Tissue Sarcoma AJCC v7

## Interventions

- **DRUG:** Dacarbazine
- **DRUG:** Doxorubicin Hydrochloride
- **BIOLOGICAL:** Filgrastim
- **DRUG:** Ifosfamide
- **OTHER:** Laboratory Biomarker Analysis
- **RADIATION:** Radiation Therapy
- **DRUG:** Thalidomide
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT00089544
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06-17
- **Primary completion:** 2011-09-27
- **Final completion:** 2013-11-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089544, "Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00089544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*